ESRX : Analysis & Opinions

  1. Express Scripts Names a New CEO

    September 11, 2015
    The doctor, it seems, has ordered a change in management. That's the case at prescription drug benefits manager Express ...
  2. How Express Scripts Makes Money

    July 29, 2015
    The pharmacy benefit manager claims to lower prescription drug costs for consumers, medical providers, and health insurance ...
  3. How does the role of Medicare/Medicaid affect the drugs sector ...

    July 27, 2015
    Read about the impact of Medicare and Medicaid on the drugs sector in the United States and how some doctors get rich by ...
  4. What Is the Pharmacy Benefit Management Industry?

    July 2, 2015
    PBMs, acting as third party administrators and negotiators, are essential to facilitating transactions between the moving ...
  5. Trade Healthcare Providers with this ETF

    February 27, 2015
    In good times and bad times one of the best sectors for retail investors to look into is the healthcare providers. Here's ...
  6. McKesson CEO's $159 Million Pension: Should Shareholders Be Concerned?

    June 27, 2013
    Drug distribution company McKesson (NYSE:MCK) revealed in a June 21 regulatory filing that had CEO John Hammergren retired ...
  7. Novo Nordisk A/S and More Big Movers in Healthcare on November ...

    November 6, 2012
    The Nasdaq remains relatively unchanged, the S&P 500 has climbed 0.4% and the Dow is trading up 0.6% so far today. The ...
  8. AmerisourceBergen Looks Very Healthy

    June 18, 2012
    The drug distribution industry has great growth prospects and the leading players, including AmerisourceBergen, are trading ...
  9. CVS Caremark’s Dispensing A Modest Outlook

    February 10, 2012
    Much of CVS Caremark's future growth is already discounted in the share price.
  10. U.S. Stocks: Why America Is Recovering From The Debt Bust Faster ...

    January 24, 2012
    Private debt levels are helping America see a faster recovery from debt than Eurpoe is experiencing.
  11. 2011's Biggest Mergers and Acquisitions

    December 30, 2011
    M&A activity rebounded in a big way in 2011. Here's a look back at the biggest mergers and acquisitions during the year.
  12. What Is Walgreen's Next Trick?

    September 30, 2011
    Walgreen is doing okay today, but tomorrow is a much bigger question.
  13. CVS Still Needs to Prove Itself

    August 9, 2011
    A potential merger of two archrivals could increase the competitive environment for CVS significantly.
  14. Teva And Mylan Show Some Value Remains In Generics

    August 4, 2011
    These two generics companies seem to be heading in opposite directions, but the values are similar.
  15. 3 Stocks Swirling the Drain

    July 29, 2011
    Borders, the second largest bookstore in the US—like Blockbuster before it—failed to surprise Wall Street as it went under ...
  16. PBMs: Making The Most Of Generics

    February 3, 2011
    PBMs stand to benefit from the generic introduction of blockbuster drugs. Has the market fully discounted the opportunity?
  17. The IPO Crash Of Y2K

    July 21, 2009
    Performance of IPOs has been lackluster for the first part of this century. In the long run, are they worth the effort?
  18. Medco A Top Pharmacy Stock Pick

    March 25, 2009
    Medco looks to be the healthiest company among its peers, but is now the time to buy?
  19. Express Scripts: Trading Within A Symmetrical Triangle

    August 7, 2008
    Traders will keep a close watch on ESRX as it follows this well-formed pattern.
Trading Center
You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!